Search results
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 2 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
Gateway - The Root
The Root· 2 days agoHealth expert, Dr. Melissa Clarke, dropped some reasons to The Root about Covid and why it’s still around. Variants can have an advantage over the parent virus, which allows them to infect people more easily or become more deadly.
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoAdministration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant. “Based on the totality of the evidence ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Dr. Anthony Fauci says keeping schools shut down for so long amid COVID "was not a good idea"
CBS News· 1 day agoDr. Anthony Fauci is reflecting on some of the actions taken in response to the COVID pandemic,...
L.A. County COVID cases, hospitalizations rise amid FLiRT variants summer uptick
LA Times via Yahoo News· 4 days agoWhile the numbers of coronavirus cases and hospitalizations are relatively low, the uptick is an...
COMMENTARY: Misleading BMJ Public Health paper on COVID-19 excess mortality needs to be retracted
Center for Infectious Disease Research and Policy· 2 days agoIn a publication in BMJ Public Health on June 3, Saskia Mostert, MD, PhD, and colleagues discuss...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 5 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
Summer COVID surge approaches in Seattle area as travel season begins
The Columbian· 2 days agoA summer COVID-19 surge is on its way through Seattle and the region. Infection rates and emergency...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 6 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...